Notes

Working with Dog radiometabolites.
In humans, several members of the CEACAM receptor family have been shown to interact with intestinal pathogens in an inflammatory context. While CEACAMs have long been thought to be only present in mammals, recent studies have identified ceacam genes in other vertebrates, including teleosts. The function of these related genes remains however largely unknown. To gain insight into the function of CEACAM proteins in fish, we undertook the study of a putative member of the family, CEACAMz1, identified in Danio rerio. Sequence analysis of the ceacamz1 gene product predicted a GPI-anchored extracellular protein containing eleven immunoglobulin domains but revealed no evident orthology with human CEACAMs. Using a combination of RT-PCR analyses and in situ hybridization experiments, as well as a fluorescent reporter line, we showed that CEACAMz1 is first expressed in discrete cells on the ventral skin of zebrafish larvae and later on in the developing gills. This distribution remains constant until juvenile stage is reached, at which point CEACAMz1 is almost exclusively expressed in gills. We further observed that at late larval stages, CEACAMz1-expressing cells mostly localize on the afferent side of the branchial filaments and possibly in the inter-lamellar space. Using immunolabelling and 3D-reconstructions, we showed that CEACAMz1 is expressed in cells from the uppermost layer of skin epidermis. These cells are embedded within the keratinocytes pavement and we unambiguously identified them as proton-pump rich ionocytes (HR cells). As the expression of ceacamz1 is turned on concomitantly to that of other known markers of HR cells, we propose that ceacamz1 may serve as a novel marker of mature HR cells from the zebrafish epidermis.Summer weed species, including Echinochloa colona, are becoming problematic in the eastern grain region of Australia, but cover crops can be useful to suppress weeds during the summer fallow period. The present study evaluated the growth and seed production of E. colona grown alone or with four and eight cover crop plants per pot (i.e., 80 and 160 plants m-2). Four legume (cowpea, lablab, pigeonpea, and soybean) and two grass (forage sorghum and Japanese millet) cover crops were used. Interference by cover crops reduced the height, the number of leaves and tillers, inflorescence number, seed production, and biomass of this weed than when it was grown alone. Cover crops differed in their ability to suppress the growth and seed production of E. colona. The effect of cover crop density on the studied attributes was non-significant in most cases. Pigeonpea as a cover crop was the least effective in suppressing the growth and seed production of E. colona. In general, leguminous cover crops exhibited less suppression of E. colona than grasses. Forage sorghum was most efficient in reducing the growth of this weed. Forage sorghum and Japanese millet reduced E. colona leaf and tiller numbers per plant by 90 and 87%, respectively. These cover crops reduced E. colona leaf number to only 17 per plant as against 160 per plant recorded without cover crops. Inflorescence number per E. colona plant growing alone was as high as 48. However, it was reduced by 20-92% when this weed was grown with cover crop plants. E. colona's seed production was significantly suppressed by all the cover crops, except pigeonpea. Biomass of E. colona was suppressed largely by forage sorghum and Japanese millet compared to other cover crops. Among the cover crops, pigeonpea produced the lowest biomass of 11 g pot-1, and the highest biomass (114 g pot-1) was produced by forage sorghum. The study demonstrated the usefulness of cover crops, especially forage sorghum and Japanese millet, to suppress the growth and seed output of E. colona.
There is conflicting evidence whether limb amputation (LA) disproportionately affects indigenous populations. To better understand this disparity, we compared the LA incidence rate between First Nations persons registered under the Indian Act of Canada (RI) and the general population (GP) in Saskatchewan.

We used Saskatchewan's retrospective administrative data containing hospital discharge LA cases, demographic characteristics (age and sex), and residents population reported in the database stratified by RI and GP from 2006-2019. The LA cases for each stratified group were first disaggregated into three broad categories overall LA (all reported LA), primary LA (first reported LA), and subsequent LA (revision or contralateral LA), with each category further split into the level of amputation defined as major amputation (through/above the ankle/wrist joint) and minor amputation (below the ankle/wrist joint). LA rates were calculated using LA cases as the numerator and resident population as the denominator population. This disparity exists for all variables examined, including overall, primary, and subsequent LA rates, level of amputation, sex, and age. Amplification of the disparities will continue if the rates of change maintain their current trajectories. These results underscore the need for a better understanding of underlying causes to develop a targeted intervention in these groups.
Longer-term consequences after SARS-CoV-2 infection are becoming an important burden to societies and healthcare systems. Data on post-COVID-19 syndrome in the general population are required for the timely planning of healthcare services and resources. The objective of this study was to assess the prevalence of impaired health status and physical and mental health symptoms among individuals at least six months after SARS-CoV-2 infection, and to characterize their healthcare utilization.

This population-based prospective cohort study (Zurich SARS-CoV-2 Cohort) enrolled 431 adults from the general population with polymerase chain reaction-confirmed SARS-CoV-2 infection reported to health authorities between 27 February 2020 and 05 August 2020 in the Canton of Zurich, Switzerland. We evaluated the proportion of individuals reporting not to have fully recovered since SARS-CoV-2 infection, and the proportion reporting fatigue (Fatigue Assessment Scale), dyspnea (mMRC dyspnea scale) or depression (DASS-21) at e.

In this population-based study, a relevant proportion of participants suffered from longer-term consequences after SARS-CoV-2 infection. With millions infected across the world, our findings emphasize the need for the timely planning of resources and patient-centered services for post-COVID-19 care.
In this population-based study, a relevant proportion of participants suffered from longer-term consequences after SARS-CoV-2 infection. With millions infected across the world, our findings emphasize the need for the timely planning of resources and patient-centered services for post-COVID-19 care.
Evaluation of skin organ doses in six different cone-beam computed tomography scanners (CBCT) dedicated to dentomaxillofacial imaging. Our hypothesis is that the dose varies between different devices, protocols and skin areas.

An anthropomorphic adult head and neck phantom was used to which a dosimeter (Waterproof Farmer® Chamber, PTW, Freiburg, Germany) was attached to anatomic landmarks of both parotid glands, both ocular lenses, the thyroid gland and the neurocranium. CBCT examinations were performed on six different CBCT devices dedicated to dentomaxillofacial imaging with standard settings and, if available, also in high dose settings. Measurements were repeated five times each.

The measured mean skin doses ranged from 0.48 to 2.21 mGy. The comparison of the region based dose evaluation showed a high correlation between the single measurements. Furthermore, the distribution of doses between regions was similar in all devices, except that four devices showed side differences for the dose of the paro studies should be performed to confirm these results.
Repeated measurements of skin organ doses in six different CBCT scanners using a surface dosimeter showed side differences in distribution of dose in five devices for the parotid and lens region. Additionally, significant dose differences between the devices could be detected. Further studies should be performed to confirm these results.Aberrant DNA methylation profiles have been implicated in numerous cardiovascular diseases; however, few studies have investigated how these epigenetic modifications contribute to stroke recurrence. The aim of this study was to identify methylation loci associated with the time to recurrent cerebro- and cardiovascular events in individuals of European and African descent. DNA methylation profiles were generated for 180 individuals from the Vitamin Intervention for Stroke Prevention clinical trial using Illumina HumanMethylation 450K BeadChip microarrays, resulting in beta values for 470,871 autosomal CpG sites. Ethnicity-stratified survival analyses were performed using Cox Proportional Hazards regression models for associations between each methylation locus and the time to recurrent stroke or composite vascular event. Results were validated in the Vall d'Hebron University Hospital cohort from Barcelona, Spain. Network analyses of the methylation loci were generated using weighted gene coexpression network analysis. Primary analysis identified four significant loci, cg04059318, ch.2.81927627R, cg03584380, and cg24875416, associated with time to recurrent stroke. Secondary analysis identified three loci, cg00076998, cg16758041, and cg02365967, associated with time to composite vascular endpoint. Locus cg03584380, which is located in an intron of ZDHHC6, was replicated in the Vall d'Hebron University Hospital cohort. The results from this study implicate the degree of methylation at cg03584380 is associated with the time of recurrence for stroke or composite vascular events across two ethnically diverse groups. Furthermore, modules of loci were associated with clinical traits and blood biomarkers including previous number of strokes, prothrombin fragments 1 + 2, thrombomodulin, thrombin-antithrombin complex, triglyceride levels, and tissue plasminogen activator. Ultimately, these loci could serve as potential epigenetic biomarkers that could identify at-risk individuals in recurrence-prone populations.The Nemegt Formation of the Gobi Desert of Mongolia has produced one of the most abundant and diverse oviraptorosaur records globally. However, the caenagnathid component of this fauna remains poorly known. Two caenagnathid taxa are currently recognized from the Nemegt Formation Elmisaurus rarus and Nomingia gobiensis. Because these taxa are known from mostly non-overlapping material, there are concerns that they could represent the same animal. A partial, weathered caenagnathid skeleton discovered adjacent to the holotype quarry of Nomingia gobiensis is referable to Elmisaurus rarus, revealing more of the morphology of the cranium, mandible, pectoral girdle, and pubis. Despite metatarsals clearly exhibiting autapomorphies of Elmisaurus rarus, overlapping elements are identical to those of Nomingia gobiensis, and add to a growing body of evidence that these taxa represent a single morphotype. In the absence of any positive evidence for two caenagnathid taxa in the Nemegt Formation, Nomingia gobiensis is best regarded as a junior synonym of Elmisaurus rarus.
My Website: